Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
0.3290
Dollar change
+0.0209
Percentage change
6.80
%
Index- P/E- EPS (ttm)-0.58 Insider Own25.59% Shs Outstand35.33M Perf Week17.12%
Market Cap12.21M Forward P/E- EPS next Y- Insider Trans0.65% Shs Float27.62M Perf Month-7.32%
Income-16.31M PEG- EPS next Q- Inst Own12.78% Short Float1.98% Perf Quarter-8.43%
Sales0.00M P/S- EPS this Y- Inst Trans-1.20% Short Ratio1.08 Perf Half Y-66.77%
Book/sh0.12 P/B2.75 EPS next Y- ROA-212.70% Short Interest0.55M Perf Year-81.20%
Cash/sh0.03 P/C11.86 EPS next 5Y- ROE-626.62% 52W Range0.23 - 1.87 Perf YTD-58.03%
Dividend Est.- P/FCF- EPS past 5Y-311.69% ROI-356.85% 52W High-82.41% Beta-0.89
Dividend TTM- Quick Ratio1.60 Sales past 5Y-20.00% Gross Margin- 52W Low42.86% ATR (14)0.03
Dividend Ex-Date- Current Ratio1.60 EPS Y/Y TTM9.85% Oper. Margin0.00% RSI (14)55.95 Volatility9.62% 11.23%
Employees7 Debt/Eq0.56 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price4.00
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q78.70% Payout- Rel Volume0.48 Prev Close0.31
Sales Surprise- EPS Surprise30.00% Sales Q/Q- Earnings- Avg Volume508.62K Price0.33
SMA2012.64% SMA50-0.88% SMA200-53.44% Trades Volume243,330 Change6.80%
May-30-24 08:47AM
May-13-24 09:53AM
May-08-24 08:47AM
May-02-24 08:47AM
Apr-02-24 08:47AM
09:00AM Loading…
Feb-26-24 09:00AM
Feb-07-24 07:30AM
Jan-04-24 07:30AM
Dec-06-23 07:00AM
Dec-05-23 07:00AM
Dec-04-23 07:30AM
Oct-31-23 09:01AM
07:00AM
Oct-24-23 08:30AM
Oct-11-23 07:30AM
09:15AM Loading…
Oct-09-23 09:15AM
Oct-04-23 07:30AM
Oct-03-23 07:00AM
Sep-27-23 07:30AM
Sep-14-23 07:30AM
Sep-11-23 07:30AM
Aug-30-23 01:00PM
Aug-17-23 07:30AM
Aug-01-23 08:00AM
Jun-16-23 04:00PM
Jun-14-23 09:28AM
Jun-09-23 07:00AM
May-17-23 08:30AM
May-10-23 03:00PM
Apr-18-23 07:30AM
09:45AM Loading…
Mar-29-23 09:45AM
Mar-21-23 07:00AM
Feb-07-23 08:00AM
Jan-31-23 07:30AM
Nov-22-22 07:00AM
Nov-15-22 07:00AM
Nov-08-22 07:00AM
Nov-02-22 07:00AM
Sep-21-22 07:00AM
May-17-22 07:00AM
Apr-19-22 07:00AM
Apr-13-22 04:05PM
07:00AM
Jan-20-22 08:00AM
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeSilva TaraDirectorJan 12 '24Buy0.582,2661,30532,266Jan 16 08:14 PM
Cogley BrianChief Financial OfficerJan 10 '24Buy0.675,0003,35030,000Jan 17 04:03 PM
Mehalick DavidCEO and PresidentJan 08 '24Buy0.6620,00413,2632,782,615Jan 09 05:30 PM
Salkind GeneDirectorJan 05 '24Buy0.6911,6008,004284,056Jan 09 05:31 PM
Yerace Daniel AlexanderVP of OperationsJan 05 '24Buy0.6910,8507,4861,071,455Jan 09 05:32 PM
Cochran Christopher P.DirectorJan 05 '24Buy0.777,0005,39037,000Jan 09 05:30 PM
Mehalick DavidCEO and PresidentJan 05 '24Buy0.695,0503,4842,762,611Jan 09 05:30 PM
Salkind GeneDirectorAug 29 '23Buy1.014,0064,0464,046Aug 30 03:15 PM
Salkind GeneDirectorAug 25 '23Buy0.9128,63826,06128,638Aug 30 03:15 PM
Calise ChrisDirectorAug 23 '23Buy0.9411,58210,8791,464,897Aug 31 04:01 PM